Saliva Hst-5 (μg/ml) % killing
HIV+ (M) 4.82* 18.62
HIV+ (L) 1.1 0
HIV- (H) 8.67* 35.86
HIV- (M) 5.62* 19.31
HIV- (L) 2.6 0
Experiments were performed on three separate occasions. (L) % killing was compared with rest of the groups. * P<0.05
Table 3: Anti-candidal potency of characterized pooled saliva from the HIVand HIV+ groups.
Goto home»